Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia

OBJECTIVE: To determine whether children aged 3-59 months with mild or non-symptomatic human immunodeficiency virus (HIV) infection and WHO-defined severe pneumonia have a higher failure rate than do HIV-uninfected children when treated with the standard WHO treatment of parenteral penicillin or ora...

Full description

Bibliographic Details
Main Authors: Jeena Prakash, Thea Donald M, MacLeod William B, Chisaka Noel, Fox Matthew P, Coovadia HM, Qazi Shamim
Format: Article
Language:English
Published: The World Health Organization 2006-01-01
Series:Bulletin of the World Health Organization
Subjects:
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000400010
_version_ 1827332588933480448
author Jeena Prakash
Thea Donald M
MacLeod William B
Chisaka Noel
Fox Matthew P
Coovadia HM
Qazi Shamim
author_facet Jeena Prakash
Thea Donald M
MacLeod William B
Chisaka Noel
Fox Matthew P
Coovadia HM
Qazi Shamim
author_sort Jeena Prakash
collection DOAJ
description OBJECTIVE: To determine whether children aged 3-59 months with mild or non-symptomatic human immunodeficiency virus (HIV) infection and WHO-defined severe pneumonia have a higher failure rate than do HIV-uninfected children when treated with the standard WHO treatment of parenteral penicillin or oral amoxicillin. METHODS: This study was a planned sub-analysis of a randomized trial of 3-59-month-old children presenting with WHO-defined severe pneumonia (the APPIS study). We included two sites with high HIV prevalence in Durban, South Africa and Ndola, Zambia. Primary outcome measures were clinical treatment failure at day 2 and day 14. CLINICALTRIALS.GOV IDENTIFIER: CT00227331http://www.clinicaltrialsgov/show/NCT00227331). FINDINGS: Of the 523 children enrolled, HIV status was known for 464 participants; 106 (23%) of these were infected with HIV. By day 2, 57 (12.3%) children had failed treatment and 110 (23.7%) failed by day 14. Twenty (18.9%) HIV-infected children failed by day 2 compared with 37 (10.3%) uninfected children (adjusted odds ratio (OR) 2.07; 95% confidence interval (CI): 1.07-4.00). Thirty-four (32.1%) HIV-infected children failed treatment by day 14 compared with 76 (21.2%) uninfected children (adjusted OR 1.88; 95% CI: 1.11-3.17). Analysis stratified by age showed that the greatest differential in treatment failure at day 2 and day 14 occurred in the children aged 3-5 months. CONCLUSIONS: HIV-infected children with severe pneumonia fail WHO-standard treatment with parenteral penicillin or amoxicillin at day 2 and day 14 more often than do HIV-uninfected children, especially young infants. Standard case management of acute respiratory infection (ARI) using WHO treatment guidelines is inadequate in areas of high HIV prevalence and reappraisal of empiric antimicrobial therapy is urgently needed for severe pneumonia associated with HIV-1.
first_indexed 2024-03-07T17:03:12Z
format Article
id doaj.art-b8081b24f0d74d168a0af6c81c4cdeb9
institution Directory Open Access Journal
issn 0042-9686
language English
last_indexed 2024-03-07T17:03:12Z
publishDate 2006-01-01
publisher The World Health Organization
record_format Article
series Bulletin of the World Health Organization
spelling doaj.art-b8081b24f0d74d168a0af6c81c4cdeb92024-03-03T03:15:53ZengThe World Health OrganizationBulletin of the World Health Organization0042-96862006-01-01844269275Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumoniaJeena PrakashThea Donald MMacLeod William BChisaka NoelFox Matthew PCoovadia HMQazi ShamimOBJECTIVE: To determine whether children aged 3-59 months with mild or non-symptomatic human immunodeficiency virus (HIV) infection and WHO-defined severe pneumonia have a higher failure rate than do HIV-uninfected children when treated with the standard WHO treatment of parenteral penicillin or oral amoxicillin. METHODS: This study was a planned sub-analysis of a randomized trial of 3-59-month-old children presenting with WHO-defined severe pneumonia (the APPIS study). We included two sites with high HIV prevalence in Durban, South Africa and Ndola, Zambia. Primary outcome measures were clinical treatment failure at day 2 and day 14. CLINICALTRIALS.GOV IDENTIFIER: CT00227331http://www.clinicaltrialsgov/show/NCT00227331). FINDINGS: Of the 523 children enrolled, HIV status was known for 464 participants; 106 (23%) of these were infected with HIV. By day 2, 57 (12.3%) children had failed treatment and 110 (23.7%) failed by day 14. Twenty (18.9%) HIV-infected children failed by day 2 compared with 37 (10.3%) uninfected children (adjusted odds ratio (OR) 2.07; 95% confidence interval (CI): 1.07-4.00). Thirty-four (32.1%) HIV-infected children failed treatment by day 14 compared with 76 (21.2%) uninfected children (adjusted OR 1.88; 95% CI: 1.11-3.17). Analysis stratified by age showed that the greatest differential in treatment failure at day 2 and day 14 occurred in the children aged 3-5 months. CONCLUSIONS: HIV-infected children with severe pneumonia fail WHO-standard treatment with parenteral penicillin or amoxicillin at day 2 and day 14 more often than do HIV-uninfected children, especially young infants. Standard case management of acute respiratory infection (ARI) using WHO treatment guidelines is inadequate in areas of high HIV prevalence and reappraisal of empiric antimicrobial therapy is urgently needed for severe pneumonia associated with HIV-1.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000400010Pneumonia/drug therapyHIV infectionsInfantChildPenicillinsAmoxicillinSouth AfricaZambia
spellingShingle Jeena Prakash
Thea Donald M
MacLeod William B
Chisaka Noel
Fox Matthew P
Coovadia HM
Qazi Shamim
Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia
Bulletin of the World Health Organization
Pneumonia/drug therapy
HIV infections
Infant
Child
Penicillins
Amoxicillin
South Africa
Zambia
title Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia
title_full Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia
title_fullStr Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia
title_full_unstemmed Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia
title_short Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia
title_sort failure of standard antimicrobial therapy in children aged 3 59 months with mild or asymptomatic hiv infection and severe pneumonia
topic Pneumonia/drug therapy
HIV infections
Infant
Child
Penicillins
Amoxicillin
South Africa
Zambia
url http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000400010
work_keys_str_mv AT jeenaprakash failureofstandardantimicrobialtherapyinchildrenaged359monthswithmildorasymptomatichivinfectionandseverepneumonia
AT theadonaldm failureofstandardantimicrobialtherapyinchildrenaged359monthswithmildorasymptomatichivinfectionandseverepneumonia
AT macleodwilliamb failureofstandardantimicrobialtherapyinchildrenaged359monthswithmildorasymptomatichivinfectionandseverepneumonia
AT chisakanoel failureofstandardantimicrobialtherapyinchildrenaged359monthswithmildorasymptomatichivinfectionandseverepneumonia
AT foxmatthewp failureofstandardantimicrobialtherapyinchildrenaged359monthswithmildorasymptomatichivinfectionandseverepneumonia
AT coovadiahm failureofstandardantimicrobialtherapyinchildrenaged359monthswithmildorasymptomatichivinfectionandseverepneumonia
AT qazishamim failureofstandardantimicrobialtherapyinchildrenaged359monthswithmildorasymptomatichivinfectionandseverepneumonia